Keywords: barr, 2nd-qtr, profit, rises, generic, drugmaker, pharmaceuticals
Barr's 2nd-qtr 2008 profit rises 27%
Article | 18 August 2008
US generic drugmaker Barr Pharmaceuticals says its second-quarter 2008 profit rose 26.7% year-on-year to $57.0 million, or $0.52 per share, in line with expectations, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
